SEP
BSX icon

Signature Equity Partners’s Boston Scientific BSX Stock Holding History

Signature Equity Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Buy
642
+524
+444% +$28.5K 0.01% 572
2026
Q1 		$7.41K Sell
118
-56
-32% -$4.48K ﹤0.01% 872
2025
Q4 		$16.6K Buy
+174
New +$17.1K 0.01% 671

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Signature Equity Partners's BSX Position: Q2 2026 in Review

Signature Equity Partners increased its Boston Scientific (BSX) stake by 444% in Q2 2026, buying an estimated $28.5K and bringing the position to 642 shares worth $27.4K. The position accounts for 0.01% of the portfolio, ranked #572.

Signature Equity Partners first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Signature Equity Partners held 642 shares of Boston Scientific worth $27.4K as of Q2 2026.
  • Signature Equity Partners bought 524 Boston Scientific shares in Q2 2026, an estimated $28.5K.
  • Boston Scientific made up 0.01% of Signature Equity Partners's portfolio in Q2 2026, its #572 holding.
  • Signature Equity Partners first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.